These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 26101161)

  • 1. Molecular basis and clinical significance of genetic aberrations in B-cell precursor acute lymphoblastic leukemia.
    Ghazavi F; Lammens T; Van Roy N; Poppe B; Speleman F; Benoit Y; Van Vlierberghe P; De Moerloose B
    Exp Hematol; 2015 Aug; 43(8):640-53. PubMed ID: 26101161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interphase-FISH screening for eight common rearrangements in pediatric B-cell precursor acute lymphoblastic leukemia.
    Hutspardol S; Pakakasama S; Kanta K; Nuntakarn L; Anurathapan U; Sirachainan N; Songdej D; Sawangpanich R; Tiyasirichokchai R; Rerkamnuaychoke B; Hongeng S
    Int J Lab Hematol; 2013 Aug; 35(4):406-15. PubMed ID: 23190578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clinical relevance of chromosomal and genomic abnormalities in B-cell precursor acute lymphoblastic leukaemia.
    Moorman AV
    Blood Rev; 2012 May; 26(3):123-35. PubMed ID: 22436535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous occurrence of ETV6-RUNX1 and BCR-ABL1 (e1a2) transcripts in a child with B-cell acute lymphoblastic leukemia.
    Balatzenko G; Guenova M; Kalinova I; Belcheva M; Hristozova H; Kaleva V
    Cancer Genet; 2013 Mar; 206(3):97-101. PubMed ID: 23491079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD99 expression is strongly associated with clinical outcome in children with B-cell precursor acute lymphoblastic leukaemia.
    Chen D; Camponeschi A; Wu Q; Gerasimcik N; Li H; Shen X; Tan Y; Sjögren H; Nordlund J; Lönnerholm G; Abrahamsson J; Fogelstrand L; Mårtensson IL
    Br J Haematol; 2019 Feb; 184(3):418-423. PubMed ID: 30484860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High STAP1 expression in DUX4-rearranged cases is not suitable as therapeutic target in pediatric B-cell precursor acute lymphoblastic leukemia.
    Steeghs EMP; Bakker M; Hoogkamer AQ; Boer JM; Hartman QJ; Stalpers F; Escherich G; de Haas V; de Groot-Kruseman HA; Pieters R; den Boer ML
    Sci Rep; 2018 Jan; 8(1):693. PubMed ID: 29330417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Minimal residual disease values discriminate between low and high relapse risk in children with B-cell precursor acute lymphoblastic leukemia and an intrachromosomal amplification of chromosome 21: the Austrian and German acute lymphoblastic leukemia Berlin-Frankfurt-Munster (ALL-BFM) trials.
    Attarbaschi A; Mann G; Panzer-Grümayer R; Röttgers S; Steiner M; König M; Csinady E; Dworzak MN; Seidel M; Janousek D; Möricke A; Reichelt C; Harbott J; Schrappe M; Gadner H; Haas OA
    J Clin Oncol; 2008 Jun; 26(18):3046-50. PubMed ID: 18565891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular genetics of acute lymphoblastic leukemia.
    Teitell MA; Pandolfi PP
    Annu Rev Pathol; 2009; 4():175-98. PubMed ID: 18783329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Normal karyotype CALLA-positive adult pre-B ALL: dismal outcome with chemotherapy for patients with loss/gain of ABL1 and/or BCR FISH signals.
    Abou Mourad YR; Bhargava R; Bruyère H; Gillian T; Barnett MJ; Forrest DL; Nevill TJ; Toze CL; Nantel SH; Shepherd JD
    Clin Lymphoma Myeloma Leuk; 2013 Jun; 13(3):281-6. PubMed ID: 23098889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute lymphoblastic leukaemia with an e1a3 BCR-ABL1 fusion.
    Langabeer SE; Haslam K; Kelly J; Leahy M; Vandenberghe E
    Acta Haematol; 2011; 126(4):214-5. PubMed ID: 21934295
    [No Abstract]   [Full Text] [Related]  

  • 11. High frequency of BTG1 deletions in patients with BCR-ABL1-positive acute leukemia.
    Xie J; Wang Q; Wang Q; Yao H; Wen L; Ma L; Wu D; Chen S
    Cancer Genet; 2014 May; 207(5):226-30. PubMed ID: 24998463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New genetic abnormalities and treatment response in acute lymphoblastic leukemia.
    Meijerink JP; den Boer ML; Pieters R
    Semin Hematol; 2009 Jan; 46(1):16-23. PubMed ID: 19100364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New strategies in acute lymphoblastic leukemia: translating advances in genomics into clinical practice.
    Mullighan CG
    Clin Cancer Res; 2011 Feb; 17(3):396-400. PubMed ID: 21149616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting the thioredoxin system as a novel strategy against B-cell acute lymphoblastic leukemia.
    Fidyt K; Pastorczak A; Goral A; Szczygiel K; Fendler W; Muchowicz A; Bartlomiejczyk MA; Madzio J; Cyran J; Graczyk-Jarzynka A; Jansen E; Patkowska E; Lech-Maranda E; Pal D; Blair H; Burdzinska A; Pedzisz P; Glodkowska-Mrowka E; Demkow U; Gawle-Krawczyk K; Matysiak M; Winiarska M; Juszczynski P; Mlynarski W; Heidenreich O; Golab J; Firczuk M
    Mol Oncol; 2019 May; 13(5):1180-1195. PubMed ID: 30861284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High expression of miR-125b-2 and SNORD116 noncoding RNA clusters characterize ERG-related B cell precursor acute lymphoblastic leukemia.
    Vendramini E; Giordan M; Giarin E; Michielotto B; Fazio G; Cazzaniga G; Biondi A; Silvestri D; Valsecchi MG; Muckenthaler MU; Kulozik AE; Gattei V; Izraeli S; Basso G; Te Kronnie G
    Oncotarget; 2017 Jun; 8(26):42398-42413. PubMed ID: 28415578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in the molecular pathobiology of B-lymphoblastic leukemia.
    Zhou Y; You MJ; Young KH; Lin P; Lu G; Medeiros LJ; Bueso-Ramos CE
    Hum Pathol; 2012 Sep; 43(9):1347-62. PubMed ID: 22575265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Establishment of cell lines from B-cell precursor acute lymphoblastic leukemia.
    Zhang LQ; Downie PA; Goodell WR; McCabe NR; LeBeau MM; Morgan R; Sklar J; Raimondi SC; Miley D; Goldberg A
    Leukemia; 1993 Nov; 7(11):1865-74. PubMed ID: 8231254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detailed gene dose analysis reveals recurrent focal gene deletions in pediatric B-cell precursor acute lymphoblastic leukemia.
    Ivanov Öfverholm I; Tran AN; Olsson L; Zachariadis V; Heyman M; Rudd E; Syk Lundberg E; Nordenskjöld M; Johansson B; Nordgren A; Barbany G
    Leuk Lymphoma; 2016 Sep; 57(9):2161-70. PubMed ID: 27090575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ABL deletion without associated BCR-ABL in precursor B-cell acute lymphoblastic leukemia.
    Lo A; Gu G; Liu M; Dev VG
    Leuk Res; 2009 Aug; 33(8):e98-103. PubMed ID: 19282030
    [No Abstract]   [Full Text] [Related]  

  • 20. Frequency of copy number abnormalities in common genes associated with B-cell precursor acute lymphoblastic leukemia cytogenetic subtypes in Brazilian children.
    Barbosa TC; Terra-Granado E; Quezado Magalhães IM; Neves GR; Gadelha A; Guedes Filho GE; Souza MS; Melaragno R; Emerenciano M; Pombo-de-Oliveira MS
    Cancer Genet; 2015 Oct; 208(10):492-501. PubMed ID: 26277549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.